Company attributes
Industry
B2X
CEO
Founder
Pitchbook URL
Legal Name
Prevail Therapeutics, Inc.,
Parent Organization
Legal classification
Number of Employees (Ranges)
11 – 50
Email Address
patients@prevailtherapeutics.com
info@prevailtherapeutics.com0
Phone Number
+191733693100
Full Address
430 East 29th Street, Suite 1520 New York, NY 10016
CIK Number
Place of Incorporation
Investors
Founded Date
2017
Total Funding Amount (USD)
129,000,000
Latest Funding Round Date
March 27, 2019
Stock Symbol
PRVL
Exchange
Glassdoor ID
Former CEO
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Acquirer
Company Operating Status
Active
Latest Funding Round Amount (USD)
50,000,000
SIC Code
2,8360
Prevail Therapeutics is developing gene therapies intended to target the root genetic causes of Parkinson's disease and other neurodegenerative disorders. The company's goal is to develop these gene therapies through advances in human genetics and gene therapy technology.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
